Haemonetics Corp. (HAE) Tops Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $90.71 -0.1%
Financial Fact:
Research, development and engineering: 8.34M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Research, development and engineering: 8.34M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Haemonetics Corp. (NYSE: HAE) reported Q2 EPS of $0.47, $0.01 better than the analyst estimate of $0.46. Revenue for the quarter came in at $227.6 million versus the consensus estimate of $229.9 million.
For earnings history and earnings-related data on Haemonetics Corp. (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Is Treasury selloff a major issue for stock market bulls?
- Yum! Brands (YUM) PT Lowered to $180 at Argus
- UBS: 'We Believe Dollar Tree (DLTR) is Turning From a Transformation to a Growth Story'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
